Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Challenges and Breakthroughs in Neuropharmaceutics & Neuropharmacology
- Neuropharmaceutics 2018

About Neuropharmaceutics 2018

Allied Academic Publication is an amalgamation of several esteemed academic and scientific association known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies. This publishing house has been built on the basis of esteemed academic and research institutions including the College of Audiologists and Speech Language Pathologists of Ontario (CASLPO), Sonography Canada, Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) AND The Canadian Association of Neurophysiologic Monitoring (CANM).

Neuropharmaceutics 2018 is a Premier International forum to present and grasp progress in field of research based studies, developments, standards and applications of Neuropharmaceutical, Neuropharmacological and Neuro based  aspects in its broadways with its advancements in present era. Offers high quality technical studies, in which professionals and participants and with academic and research skills exploring their research works by effective  presentations like Video, Posters, and E-posters with brief demonstrations gaining expertise knowledge from all over. Neuropharmaceutics 2018 promises to be stimulating and inspirational experience in academic, professional and social spheres.

Neuropharmaceutics 2018 is the learning of how drugs influence cellular function in the nervous system, and the neural mechanism through which they influence behavior. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders including Neurodegenerative diseases known to be Parkinson’s disease and Alzheimer’s disease, Pain, Addiction, Psychological disorders and many more. 


Welcome Message

Dear Speakers, Scientific Researchers, Colleagues and Students,

Welcome to the 8th International Conference on Neuropharmceutics and Neuropharmacology held in Edinburgh, Scotland from October 8th-10th, 2018.  I am delighted to have you attend this prestigious conference. The conference will be rich with expertise and research encompassing the importance of Neuropharmceutics, Ethics, Neurotransmission Processes, Neuro-Technological Studies, among others. Participants will take away state-of the –art knowledge to apply to further research and/or practice. I look so forward to meeting each of you and welcoming you to a wonderful learning and collegial experience.

With Best Regards,

Dr. Ann Leonard-Zabel, USA

Department: Psychology

Ed.D, Nova Southeastern University

Organizing Committee Member and Keynote Speaker

Neuropharmaceutics 2018 welcomes attendees, presenters, and exhibitors from all over the world to Scotland. We are delighted to invite you all to attend and register for the 8th International Conference on Neuro Pharmaceutics and Neuro Pharmacology which is going to be held during 08-10, 2018 of October at Edinburgh,Scotland.The Organizing Committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuropharmaceutics 2018, where you will be sure to have a meaningful experience with scholars from around the world.

It is our great pleasure to invite you to 8th International Conference on Neuropharmaceutics and Neuropharmacology , which is going to be held in October 08 to 10, 2018 at Edinburgh, Scotland.

Conference Theme: Challenges and Breakthroughs in Neuropharmaceutics and Neuropharmacology

The sessions nudge you up with the novelistic thoughts and the mode of execution of Technologies that accumulate the riches in meeting the demands of Neuropharmacological and Neuropharmaceutical Barriers.

Neuropharmaceutics2018 aims to gather the Professors, Researchers, Business Delegates, Upcoming Scientific researchers, budding students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences that approaches at this outstanding event.

Neuropharmaceutics 2018 anticipates more than 250 participants around the globe with inspirational Keynote lectures, Oral and Poster presentations. Whole the team of Neuropharmaceutics 2018 promises that you will be sure to have a great experience with scholars from around the world.

All the members’ of Neuropharmaceutics 2018 Organizing Committee look forward to meet you at Edinburgh, Scotland.

Market Analysis

Market Analysis aspects:

In 2014, investors provided $3.3 billion into firms that are developing drugs for brain-destroying or psychiatric illnesses. Some big drug companies, including Johnson & Johnson, Roche and Novartis, are finding ways to reinvigorate their efforts. New medicines for severe depression, psychosis and schizophrenia could reach the market within the next few years, and treatments for Alzheimer’s, Parkinson’s and some forms of autism are a real possibility, too.

Scotland is home to over 2,000 foreign firms with a combined turnover of £100bn, including Amazon, Blackrock, HERO BPO, Internet, Mitsubishi, SKNL, Tata Steel, and United Spirits Scotland is one of the most cost-effective regions in the UK, with a quality labour force and continuous stream of talented graduates. Operating costs in Scotland are almost 30% lower than London. In 2013, Scotland was the top UK region for foreign direct investment projects outside of London according to Ernst & Young

Educational excellence in Scotland includes five universities that are mentioned in The Times Higher Education World University Rankings holding the Top 200 and it is the most highly educated country in Europe that was announced and considered according to the Office for National Statistics. Scotland has an impressive quality of graduates and skilled young population who ensures high skills with educational availability.

On Research and Development, in 2013/14, Scotland secured 33% of all R&D projects into the UK. The number of R&D projects attracted into Scotland hit a record high of 17 – an increase of 70% from previous year. Coming to the aspects of scientific success Scotland is internationally renowned for scientific expertise. The Universities of Aberdeen, Dundee, Edinburgh, Glasgow and St Andrews are rated among the top 20 best scientific institutions in the world for scientists

In Academic collaborations Scotland has 19 higher education institutes work with over 26,000 companies every year to turn R&D into new products

Scotland has more angel investment per capita than any other country in Europe. Scotland’s workforce enjoys a high quality of life, from accessible commuting times and vibrant cultural scene, to having the great outdoors on your doorstep. It’s no coincidence that in 2014 Inverness was ranked the 2nd happiest place to live in the U.K. The world-class academic sector makes a major economic contribution - our 19 universities create an annual economic impact of £7.2bn. Our higher education institutes work with over 26,000 companies every year to turn R&D into new products. In fact, Scotland scores 5.8 out of 7 for university-industry collaboration in research and development - above OECD countries such as the US, Germany and Japan. This rapidly growing sector builds on Scotland’s proven track record in digital media innovation and creative enterprise. Supporting more than 57,000 jobs, this industry covers a broad spectrum of businesses including gaming, film, TV, music, architecture, design and the arts. Scotland is home to one of the finest 3D animation studios and best-selling action series Grand Theft Auto

Importance and Scope:  

Neuropharmaceutics 2018 will be organized around the theme Challenges and Breakthroughs in Neuropharmaceutics & Neuropharmacology.

Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of Neuropharmacology: Behavioral and Molecular. The emphasis of Neuropharmacology is on the study and understanding of the actions of known exogenous and endogenous chemical agents on neurobiological processes in the mammalian nervous system. It is necessary to focus on Neuropharmacology and the use of Neuropharmaceutical to transform brain processes in the way of enhancing memory, mood, sensation, thinking and attention in people.

Neuropharmacology is a very broad region of science that encompasses many aspects of the nervous system from single neuron manipulation to entire areas of the brain, spinal cord, and peripheral nerves. To better understand the basis behind drug development, one must first understand how neurons communicate with one another.

Neuropharmaceutics 2018 focuses on discovery of therapeutic targets, and then translating those discoveries into drug and therapy development. Neuropharmaceutics is the largest potential growth sector of the pharmaceutical industry. However, this growth is blocked by the problem of the blood-brain barrier.

Why Edinburgh, Scotland?

Edinburgh, Capital of Scotland located at central eastern Scotland well known for its classic architecture, rustic buildings and stone decorations and also considered as most lively cities in Europe. Edinburgh is a City which holds fantastic positions, and one of the most beautiful cities in Europe. Well known for tourist destinations in UK. A visit here will be well worth it, considering the numerous things you can experience and know about. The structures in the Old Town have remained in their original form over the past years. Charming medieval relics are plenty in this section of the city which is fascinated for its historic identity. The general urban scenery is also a blend of ancient structures and modern architecture, which gives the city a unique character. In 1995, the Old Town was listed as a UNESCO Heritage Site views. With year round festivals, a throbbing nightlife and an entertaining arts scene, Edinburgh never falls short of interesting travel ventures for tourists. Edinburgh is a city of literature studies and it was the first city to be called the UNESCO city of Literature. Famous Visitors place includes the National Library of Scotland, the Museum of Writers, the Scottish Center of Storytelling, the Library of Poetry and many other libraries Comprises of list of famous Scottish authors included cold be of very long lists

Scotland is a part of the United Kingdom (UK) and occupies the northern third of Great Britain. Scotland’s mainland shares a border with England to the south. It is home to almost 800 small islands where it also including the northern isles of Shetland and Orkney, the Hebrides, Arran and Skye. Situated within a vibrant Europe, Scotland has a progressive nation built on dynamism, creativity and the fabulous warmth of its people. Both at Edinburgh and Scotland you will find a wide range of Scottish facts and figures that are isolated from ancient and historical years from information with its diverse and dramatic landscape and natural resources to tales from its fascinating history to facts about Scotland’s population, economy and industry.

Education system in Scotland is internationally renowned and gives rise to a motivated workforce. Scotland also has top universities and with academic doctoral research graduates, each contributing to an increasingly better educated and skilled population showing keen knowledge acquiring and with a progressive interests in Educational systems.

Why to attend?

8th International Conference on Neuropharmaceutics and Neuropharmacology is a unique platform which aims to generate new ideas for Neuropharmaceutics along with the Neuropharmacological strategies which cover the Neuro based studies that could make the upcoming researchers a platform to explore their academic skills that will be beneficial across the globe. Neuropharmaceutics 2018 will witness an assembly of experts from all over aspects of Neuro related studies all over the world who will present their current cutting edge research for the betterment in this aspect.

Conference Highlights

Neuropharmaceutics and Its Importance

Neuropharmacology

Applications of Neuropharmacology

Molecular Neuropharmacology

Behavioral Neuropharmacology

Neurotransmission and Neurochemical Interactions

Chemical Signaling Systems in CNS

Neuro psychopharmacology

Targets of Drug action in CNS

Importance of Blood Brain Barriers in CNS

Neuroendocrine Integration

Neuro Immune Methodology

Cognitive Neuroscience

Neuro degeneration

Neuro Marketing Strategies

Clinical Trials

Neuro Oncology

Future Goals of Neuropharmacology


Institutes funding for Research

The statistic depicts the research and development expenditure of the entire pharmaceutical   industry of the United States from 1995 to 2014.

In 2004, the expenditure of the entire U.S. pharmaceutical industry on research and development came to 47.6 billion U.S. dollars. The US National Institutes of Health fund a Neuropharmacology Laboratory project, Universidad Pompeii Fabre, Barcelona.

Neuropharmacology Program the National Institute of Mental Health (NIMH) Mc knight Endowment Fund for Neuroscience.

The statistic depicts the research and development expenditure of the entire pharmaceutical   industry of the United States from 1995 to 2014. In 2004, the expenditure of the entire U.S. pharmaceutical industry on research and development came to 47.6 billion U.S. dollars.

Session Discussion

SESSION ON: NEUROPHARMACEUTICS AND ITS IMPORTANCE

Neuropharmaceutics studies include targeted enhancements and extension of Cognitive studies. Well-validated nootropics used for treating Neurological disorders, Whereas Non-pharmacological measure such as non-invasive brain stimulation employed to improve various cognitive and effective functions. Neuropharmaceutics is the learning of how drug influences cellular functions in the nervous system and the neural mechanisms through which they influence behavior. The studies are more concerned with interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion-channels and receptor protein in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders including Neurodegenerative diseases mainly Parkinson’s disease and Alzheimer’s disease, Pain, Addiction, Psychological disorders and many more

SESSION ON: NEUROPHARMACOLOGY

Deals mainly with all aspects of functioning of brain related studies. Neuropharmacology plays a major role in Identifying and determining the reason for degenerative disorders of brain. Drug targets in CNS, Chemical signaling in CNS, BBB existence, Neurotransmission functioning which is considered to be a key concept for Brain activity are considered under these Studies

SESSION ON: APPLICATIONS OF NEUROPHARMACOLOGY

Neuropharmacology publishes original and high quality research within the Neuroscience. The emphasis on Neuropharmacological studies is to understand the actions of exogenous chemical agents on Neurobiological processes in nervous systems of humans. New drugs are discovered for the advances in molecular biology and wide variety of discoveries in the Neurosciences has helped to build the foundations for knowing in brief about Neuropharmacology. Chemical Neuro anatomy and Neuropharmacology helped in discovery of major neurotransmitters in CNS and their related mechanisms

SESSION ON: MOLECULAR NEUROPHARMACOLOGY

It includes the study of morphological aspects and configurationally studies of agonists and antagonists (competitive and non-competitive) in order to develop new drug dosage regimens to treat neurodegenerative disorders including Neuropharmacological aspects. Growth and development of neurons is termed to be Neurogenesis. Neurons does not function in isolative process, they are been organized in to circuits which allow several kinds of information as neuronal circuits. Major functioning Neurotransmitter includes GABA and Serotonin in the central nervous system of vertebrate. About 14 types of 5-hydrogen tryptamine receptor sub types have been modulated, which activates protein

SESSION ON: BEHAVIORAL NEUROPHARMACOLOGY

It is concerned with complete and keen knowledge of Neuronal and Neuropharmacological based mechanisms of behavioral aspects along with its abnormalities that results to Neuropsychological effect. Non-drug reinforces are exponentially equal to that of behavioral approach to Drug addiction that are not quantitatively different. The studies which include Molecular, Biological and Morphological changes with accompanies abuse drug can also be estimated by behavioral studies. One major advantage of this approach to drug abuse is that it accounts for situations in which does not involve drugs or dosage forms, but also its accounts for situations in which there exists repeated exposure to drugs which is not followed by Addiction

SESSION ON: NEUROTRANSMISSION AND NEUROCHEMICAL INTERACTIONS

Process of Neurotransmission majorly takes place through following stages like synthesis of neurotransmitter, storage of neurotransmitter in axon terminals, formation of synaptic cleft, release of neurotransmitter, degradation or deactivation of neurotransmitter. After the release of neurotransmitter, a sequential incidence of its entrance into synaptic cleft from pre synaptic region to post synaptic region takes place that could be further combined with ionic or G-coupled proteins. Agonization can be done by ligand based mechanism. The phenomenon Co-transmission includes replace of nerve terminals with neurotransmitter. Mainly Hypo functioning processes like serotonin moiety represents biochemical traits that evaluate individuals to cause impulsive aggression with dopamine which contributes in an additive natures to serotonin deflects. Neurons can also be termed as excitable cells due to the reason that its surface membrane consists of ions which are made up of protein molecules. The neuron and neuronal structures allow chemical signals through axon terminals. Receptor based interactions in Neuropharmacological studies are mostly useful in drugs with disruption of binding process

SESSION ON: CHEMICAL SIGNALING SYSTEMS IN CNS

Neurotransmitters are generated mainly at the region of [re-synaptic clefts which are produced at post synaptic regions with excitation and inhibition actions. Non-neuronal cells release neurotropic factors that act mainly on kinase-linked receptors (tyrosine) which have regulatory action on genome expression. It also controls growth of phenotype characteristics. Neurons communicate with the help of chemical and electrical signaling which allows signals driven capabilities for conduction in end to end cells. This conduction process takes place inside the neuronal cell at the gaps present in between which is termed as Synapse where communication between neurons occurs or takes place in between the tiny gaps of synapse. Neuro Chemical transmission majorly takes place in between the pre-synaptic and post-synaptic regions of neurons which are extended and inter converted with their tendency from initial to final stages. Alteration in post synaptic neurons occurs when a neurotransmitter molecule binds to the receptor proteins. Ligand-gated ion channels and G-protein couple receptors allow rapid ion flow to the outer cell membrane regions. The neurotransmitter molecule binds to the receptor proteins and alters post synaptic neuronal function. Neurotrophins and Steroidal hormones mainly influence the function and development of the neurons and neuronal membranes

SESSION ON: NEURO PSYCHOPHARMACOLOGY

Drug effects which leads to Neuropsychological disturbances causes mental disturbances which influences behavioral changes also influences the brain functioning mechanisms

SESSION ON: TARGETS OF DRUG ACTION IN CNS

Drug mainly targets enzymes and receptor regions in the form of proteins and nucleic acid in which activities can be modified relatedly by a dosage regimen i.e. drug whose activity can be modified by a drug. The drug could be a low-molecular weight chemically inert compound or a biological compound as a recombinant protein or an antibody. The targets of Drug should show chemical, mechanical and biological responses including their in-vitro and in-vivo methods relevant to diseases. Whereas the main Neurotransmitters during the process of Neurotransmission, chemical targets includes mainly GABA, Glutamate etc. that operates through functioning of Neuromodulators like 5 Epinephrine, Prostanoids, 5-Hydroxy tryptamine, Acetylcholine that acts through both ligand gated channels and G-protein coupled receptors. Function as both Neuromodulator and Neurotransmitter. Lipid Solubility and Binding sites are the factors for chemical signaling variations; Intracellular receptors occupy hydrophobic chemical signals to cell surfaces. Agonists and Antagonists modify receptor activity.Chemical signaling in CNS takes place through blood or other fluids but is slow in functioning process. The cell body, dendrites, axon are the major regions for integration of signals in neuronal and organelle regions

SESSION ON: IMPORTANCE OF BLOOD BRAIN BARRIERS IN CNS

The term Blood-Brain Barrier has a significant importance. It describes the morphological, molecular and Neurophysiological functioning that controls efflux and influx of molecules in between the blood streams and brain. The mechanisms results a stable internal environment of brain with characteristics. The major role of blood-brain barrier (BBB) is to protect the neural tissues from variations when occurred in blood composition and toxins. The control over substance which enters or leaves the brain regions is done by endothelial cells that form blood-brain barriers. In adult’s complex cellular systems with basal membrane and number of pericytes, astrocytes are embedded. There is a differentiation in endothelial cells of brain and endothelial cells of different organs in two ways. Prevention of Para cellular movement of molecules and confirmation of no detectable Tran’s endothelial pathways the basal and specific proteins are present in membrane is involved in the development of blood brain barrier. Astrocyte foot processes contributes for brain swelling that allow water intake. Movement of solutes into brain is done by transport carriers mainly for glucose and amino acids (essential). Efflux of smaller molecules and mainly non-essential amino acids from the region of brain to blood is caused by secondary transport systems. They control the entry of Neurotransmitters to brain and help in understanding the studies related to Neuropharmacology

SESSION ON: NEUROENDOCRINE INTEGRATION

Interactions between the nervous system and the endocrine system takes place in this including also biological interactions of the cell takes place. Prominent researches on insulin receptors and hypothalamic programming plays a crucial role in integration. Transport, synthesis and secretion of hormones, interaction between the nervous, endocrine and immune systems, genetics of endocrinology including chemical signaling mechanisms. All endocrine function or regulate blood flow (or its functioning) within the gland. Hormones may affect CNS functions such as mood, anxiety and behavior. The concept of Clinical Neuroendocrinology has been greatly facilitated the technological progress in imaging techniques like MR and CT scanning

SESSION ON: NEURO IMMUNE METHODOLOGY


Neuro-immune methodology is concerned with the interactions in between immunological and nervous system functions along with auto immune diseases. Cortical system includes the study of mapping neural and neuronal systems associated with the propagation of emotion. It also focuses on the components of cortical systems with the process of recognizing facial expressions. A disorder in which spinal cord is affected known as Transverse myelitis which is heterogeneously inflammatory in actions. Whereas encephalitis cause acute inflammation of brain resulted from an auto immune or viral infection. A progressive brain disorder Huntington’s disorder causes uncontrolled movements, emotional problems and loss of thinking ability

SESSION ON: COGNITIVE NEUROSCIENCE

Deals with study of Neuronal connections which results for mental activity of brain in which biological substrates underlying the cognitive or psychological effects address for mental activity determining a brain functioning of an individual, Neurocognitivepsychology determines specific units that makes to understand morphology and functioning of the brain that involved in specific psychological process.

SESSION ON: NEURODEGENERATION

Neuronal structure gets damaged completely with its chronic effects in functioning processes where death of neuronal cells and neurons takes place. Genetic mutations are the major reason for Neuro degenerative disorders

SESSION ON: NEURO MARKETING STRATEGIES

Medical technologies are used in order to study the brain responses, stimuli and it also uses the field of Neuroscience researches in marketing strategies. Use of brain imaging technologies and scanning

SESSION ON: CLINICAL TRIALS

Clinical trials are conducted in order to examine case studies. Carrying out clinical trials for Neuropharmacological studies has become a major challenge at a number of levels. Numerous clinical interactions help us to frame queries for more rigorously designed clinical studies. Clinical researches provide valuable teaching guidance which demonstrates both classical and unusual presentations for challenges to practitioners

SESSION ON: NEURO ONCOLOGY

It is a branch of Medical Sciences majorly deals with Neuro tumors. Deals with Studies related to Brain and Spinal cord neoplasms. Neuro oncology and Pediatric Neuro oncology are the two different Concepts that differentiate the determining methodology of Neuro tumors. Neuro oncology mainly includes specially related topics like Radiation therapy, Neurosurgery, Neuro imaging, Neuropathology, social, Psychological and psychiatric aspects

SESSION ON: FUTURE GOAL OF NEUROPHARMACOLOGY

SAR’s (Structural Activity Relationship studies) includes a major area of research in Neuropharmacology which is an attempt to modify the effect or the potent drugs and their activities in relation to modification of their chemical and biochemical structures. Moreover after several investigating studies the molecular roles of delta FosB have been initiated by epigenetic studies with recent advances

Organizing Committee Members
OCM Member
Rory Fleming Richardson
Board Cerified, Diplomate in Medical Psychology, Medical Psychology
Clinical Psychologist & Neuropsychologist
Kualalumpur, Malaysia
OCM Member
Rajan Radhakrishnan
Integrated Medicine and Medical Educator (pharmacology)
Associate Professor of Integrated Medical Science, Florida Atlantic University School of Medicine
Florida, USA
OCM Member
Jennifer Fitzpatrick
Board Certificated Behavior Analyst, Behavioral Specialist, Neuroscience Associates
Ball State University
Medford, USA
OCM Member
Chris Ngcebo Mdluli
Neurophysiologist, Chief Neurophysiologist
Neurophysiologist. MSc Medicine, MA, RClinicalT(Neuro), Cert.EEG&Intgrtv NeuroScience, BA Hons Med Psych, int PhD
Pretoria, South Africa
OCM Member
Professor Sam Lingam
Executive Medical Director Consultant in Paediatrics and Adolescent Medicine , Executive Medical Director Consultant in Paediatrics and Adolescent Medicine
St. Eustatius University Medical School
London, United Kingdom
OCM Member
Horacio Capote
Director of the Division of Neuropsychiatry at the Dent Neurologic Institute, Medical Director of Addiction Services at Brylin Hospital
Director of the Division of Neuropsychiatry at the Dent Neurologic Institute
New York, USA
OCM Member
DR. (MRS) MRUDULA A. PHADKE
Member, Global Advisory Committee on Vaccine Safety, WHO, Geneva , Adjunct Professor, Maharashtra University of Health Sciences, Nashik
Director of Medical Education & Research, Govt. of Maharashtra
Mumbai, India
OCM Member
Antonio Casals Mimbrero
keynote in National & International Congress, Local Chair for Spain of the Neuromarketing Science and Business Association
Professor - Science Director Neuromarketing and NeuroStrategy, University of Barcelona
Barcelona, Spain
OCM Member
Dr. Ann Marie T. Leonard-Zabel
School Psychologist, School Neuropsychologist, Forensic Examiner, Disability Analyst, Full Professor at Curry College Curry College, Psychology
Full Professor of Psychology-Curry College
Boston, USA
OCM Member
Prof. Md Sirajul Islam
Director, Director Holy Family Red Crescent Medical College Eskaton, Dhaka
Director, Holy Family Red Crescent
Dhaka, Bangladesh
OCM Member
Dr. Amgad (M.) Rabie
International Journal of Biotechnology and Bioengineering (IJBB) Mansoura University
Pharmacist, Head of Pharmacists at The Dikernis General Hospital - Scientist, Researcher, Discoverer
cairo, Egypt
OCM Member
ASHRAF ABDELMEGUID ELTANTAWY ELBADRY
Associate proffessor at Neurosurgery dept , Mansoura University
cairo, Egypt
OCM Member
Dr. Uday Govindrao Bodhankar
International Council Member ASPR Japan
Nagpur, India
OCM Member
Dr. Mesbah Uddin Ahmed
Associate Professor & Head,Department of Paediatrics, Gonosasthya Somaj-vittick Medical College, Savar, Dhaka, Bangladesh
Secretary General, Bangladesh Paediatric Association
Dhaka, Bangladesh
OCM Member
Dr. Subashchandrabose Chinnathambi
National Chemical Laboratory, Biochemical Sciences Division
National Chemical Laboratory
Mumbai, India
OCM Member
Dr. Michele Carandente
Medical Director, Doctor of Medicine
Neurosurgeon "A. Cardarelli" Hospital
Bologna, Italy
OCM Member
Ljudmila Stojanovich, MD, PhD, FRCP
Head of Scientific Research Board, Internal medicine-rheumatologist
University of Belgrade
 Beograd, Serbia
OCM Member
Prof. Dr. med. Julia Carolin Stingl
Vice President of the Federal Institute for Drugs and Medical Devices, Work group leader at the Department of Pharmacology, University of Cologne, Department of General Pharmacology
Professor and Director Research at the Federal Institute for Drugs and Medical Devices
Washington, USA

To Collaborate Scientific Professionals around the World

Conference Date October 8-10, 2018
Speaker Oppurtunity Day 1 Day 2 Day 3
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Venue
&
Hospitality


Join The Discussion

Mail us at

neuropharma@alliedconferences.org
neuropharma@alliedconferences.org
neuropharmaceutics@alliedmeetings.org
neuropharmaceutics@alliedmeetings.org
neuropharmaceuticals@protonmail.com
neuropharmaceuticals@protonmail.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2017-2018 Allied Academies, All Rights Reserved.